Clinical Trial Update: A Study to Learn About the Effect of Higher Doses of Nusinersen (BIIB058) Given as Injections to Participants With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Risdiplam (ASCEND) [Phase 3]

View source ↗

Summary

An ongoing Phase 3 clinical trial is evaluating higher doses of nusinersen (BIIB058) given by injections in SMA patients who previously received risdiplam, to a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Muscular Atrophy

Drugs mentioned

• Nusinersen (nusinersen)
• Risdiplam (risdiplam)

Snippet

Sponsor: Biogen | Conditions: Spinal Muscular Atrophy | Phase 3 | Status: ACTIVE_NOT_RECRUITING